- £973.95m
- £1.87bn
- £174.20m
- 61
- 37
- 63
- 53
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 149 | 161 | 142 | 133 | 174 |
Cost of Revenue | |||||
Gross Profit | 111 | 122 | 81.5 | 88.2 | 118 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -9.4 | 65.6 | 354 | -11.6 | 177 |
Operating Profit | 159 | 95.8 | -212 | 145 | -3.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 137 | 72.5 | -236 | 124 | -37.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 137 | 72.1 | -236 | 124 | -37.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 137 | 72.1 | -236 | 124 | -37.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 137 | 72.1 | -236 | 124 | -37.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.787 | 0.397 | -1.21 | 0.681 | -0.179 |
Dividends per Share |